Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/192615
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGiannoccaro, Silvia-
dc.contributor.authorFerraguto, Celeste-
dc.contributor.authorPetroni, Valeria-
dc.contributor.authorMarcelly, Coline-
dc.contributor.authorNogues, Xavier-
dc.contributor.authorCampuzano Uceda, María Victoria-
dc.contributor.authorPietropaolo, Susanna-
dc.date.accessioned2023-01-25T17:15:55Z-
dc.date.available2023-01-25T17:15:55Z-
dc.date.issued2023-01-21-
dc.identifier.issn2073-4409-
dc.identifier.urihttps://hdl.handle.net/2445/192615-
dc.description.abstractWilliams-Beuren syndrome (WBS) is a neurodevelopmental disorder caused by a chromosomic microdeletion (7q11.23). WBS has been modeled by a mouse line having a complete deletion (CD) of the equivalent mouse locus. This model has been largely used to investigate the etiopathological mechanisms of WBS, although pharmacological therapies have not been identified yet. Surprisingly, CD mice were so far mainly tested in adulthood, despite the developmental nature of WBS and the critical relevance of early timing for potential treatments. Here we provide for the first time a phenotypic characterization of CD mice of both sexes during infancy and adolescence, i.e., between birth and 7 weeks of age. CD pups of both sexes showed reduced body growth, delayed sensory development, and altered patterns of ultrasonic vocalizations and exploratory behaviors. Adolescent CD mice showed reduced locomotion and acoustic startle response, and altered social interaction and communication, the latter being more pronounced in female mice. Juvenile CD mutants of both sexes also displayed reduced brain weight, cortical and hippocampal dendritic length, and spine density. Our findings highlight the critical relevance of early neurobehavioral alterations as biomarkers of WBS pathology, underlying the importance of adolescence for identifying novel therapeutic targets for this neurological disorder.-
dc.format.extent20 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherMDPI-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.3390/cells12030391-
dc.relation.ispartofCells, 2023, vol. 12, p. 391-
dc.relation.urihttps://doi.org/10.3390/cells12030391-
dc.rightscc-by (c) Giannoccaro, Silvia et al., 2023-
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/-
dc.sourceArticles publicats en revistes (Biomedicina)-
dc.subject.classificationSíndrome de Williams-
dc.subject.classificationMalalties mentals-
dc.subject.classificationMarcadors bioquímics-
dc.subject.classificationTrastorns de la conducta-
dc.subject.classificationProducció de sons pels animals-
dc.subject.classificationRatolins (Animals de laboratori)-
dc.subject.classificationAdolescència-
dc.subject.otherWilliams syndrome-
dc.subject.otherMental illness-
dc.subject.otherBiochemical markers-
dc.subject.otherBehavior disorders-
dc.subject.otherSound production by animals-
dc.subject.otherMice (Laboratory animals)-
dc.subject.otherAdolescence-
dc.titleEarly biomarkers of Williams-Beuren syndrome: a preclinical study in the CD mouse model-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec728440-
dc.date.updated2023-01-25T17:15:55Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
Appears in Collections:Articles publicats en revistes (Biomedicina)

Files in This Item:
File Description SizeFormat 
728440.pdf10.56 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons